Rio de Janeiro State University
Also known as: Curt Treu | Discipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University | Hospital Universitario Pedro Ernesto | Laboratory for Clinical and Experimental Research on Vascular Biology | Pedro Ernesto Universitary Hospital | Pedro Ernesto University | Rio de Janeiro State Research Supporting Foundation | Rio de Janeiro State Research Supporting Foundation (FAPERJ) | Rio de Janeiro State University | State University of Rio de Janeiro | Universidade do Estado do Rio de Janeiro | Universidade do Estado do Rio de Janeiro- BioVasc laboratory | Universidade do Estado do Rio de Janeiro, Brazil
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2003Last known activity
Jan 1, 2026
Timeline
1950s
- Dec 4, 1950
Rio de Janeiro State University— Founded
Drugs by trial phase (57 distinct, 47 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (31 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Erectile Dysfunction
- Esophageal and Gastric Varices
- Fatty Liver
- Fibrosis
- Flushing
- Glomerulosclerosis, Focal Segmental
- Hemorrhage
- Hot Flashes
- Hypertension
- Hypertension, Portal
- Hypertriglyceridemia
- Inflammation
- Kidney Diseases
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Leishmaniasis, Mucocutaneous
- Liver Cirrhosis
- Liver Diseases
- Lung Injury
- Non-alcoholic Fatty Liver Disease
- Oral Hemorrhage
- Pneumonia
- Pneumonia, Viral
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Severe Acute Respiratory Syndrome
Recent trials (50)
- NCT07276243Lead sponsorN/AJan 1, 2026
- NCT07276243Sponsor investigatorN/AJan 1, 2026
- NCT06288204CollaboratorN/AOct 1, 2024
- NCT06183307CollaboratorN/AMar 1, 2024
- NCT06002841CollaboratorPhase 1/Phase 2Feb 1, 2024
- NCT05689632Study directorN/AJul 15, 2022
- NCT05689632Reponsible party - principal investigatorN/AJul 15, 2022
- NCT05689632Lead sponsorN/AJul 15, 2022
- NCT05689632CollaboratorN/AJul 15, 2022
- NCT05689632Overall official - principal investigatorN/AJul 15, 2022
- NCT04561219CollaboratorPhase 2Apr 19, 2020
- NCT04020796Reponsible party - principal investigatorN/AJun 20, 2019
- NCT04020796Overall official - principal investigatorN/AJun 20, 2019
- NCT04020796Study directorN/AJun 20, 2019
- NCT04020796CollaboratorN/AJun 20, 2019
Details
- Founded
- Rio de Janeiro, BR Dec 4, 1950
- Last known activity
- Jan 1, 2026